Codexis Sells Its Hungarian Operations to Intrexon Corporation
March 13, 2014 16:30 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale...
Codexis Reports Fourth Quarter and Full Year 2013 Results
March 11, 2014 16:01 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 11, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its...
Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
February 27, 2014 07:01 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the...
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
February 25, 2014 16:01 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
Codexis to Present at 16th Annual BIO CEO & Investor Conference
February 04, 2014 16:01 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that...